摘要
目的:调查我院肾脏病患者2014年抗高血压药物的使用情况,以了解用药现状和趋势,为临床合理用药提供参考。方法:对本院肾脏病患者2014年抗高血压药物的种类、销售金额、用药频度(DDDs)和日均费用(DDC)进行统计分析。结果:2014年我院抗高血压药物的销售金额位于前3位的是替米沙坦片、苯磺酸氨氯地平片和硝苯地平控释片;DDDs值位于前3位的是替米沙坦片、苯磺酸氨氯地平胶囊和苯磺酸氨氯地平片,其DDC分别为2.30,2.14,5.78元。结论:我院抗高血压药物的使用基本合理,符合《中国高血压防治指南(2010年修订版)》的要求及肾脏病合并高血压患者的治疗需要。
Objective ： To investigate the application of antihypertensive drugs in patients with kidney diseases in our hospital in 2014 so as to understand the tendency and present situation of administration of the drugs and provide a reference for rational drug use in clinic. Methods ： The utilization of antihypertensive drugs in patients with kidney diseases in the hospital in 2014 were analyzed statistically in respect of type of antihypertensive drugs,annual consumption sum, DDDs and DDC. Results ： Telmisartan tablets, amlodipine besylate tablets and nifedipine controlled released tablets ranked the top 3 in consumption sums, while telmisartan tablets, amlodipine besylate capsules and amlodipine besylate tablets ranked the top 3 in DDDs, of antihypertensive drugs in 2014.The daily costs of telmisartan tablets, amlodipine besylate capsules and amlodipine besylate tablets were RMB 2.30, 2.14 and 5.78 respectively. Conclusion ： The utilization of antihypertensive drugs in the hospital was basically reasonable, which met the requirements in the Guideline on Prevention and Treatment of Hypertension in China（ revised in 2010） and the needs of patients with kidney diseases complicated by hypertension.
出处
《中国执业药师》
CAS
2016年第6期3-6,共4页
China Licensed Pharmacist
